Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 2
2011 2
2012 4
2013 5
2014 3
2015 4
2016 2
2017 2
2019 9
2020 10
2021 9
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Obesity and GLP-1.
Perez-Montes DE Oca A, Pellitero S, Puig-Domingo M. Perez-Montes DE Oca A, et al. Among authors: pellitero s. Minerva Endocrinol (Torino). 2021 Jun;46(2):168-176. doi: 10.23736/S2724-6507.20.03369-6. Epub 2020 Nov 19. Minerva Endocrinol (Torino). 2021. PMID: 33213122 Review.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
ENDOCRINE OBESITY: Pituitary dysfunction in obesity.
Ruiz S, Vázquez F, Pellitero S, Puig-Domingo M. Ruiz S, et al. Among authors: pellitero s. Eur J Endocrinol. 2022 Apr 21;186(6):R79-R92. doi: 10.1530/EJE-21-0899. Eur J Endocrinol. 2022. PMID: 35333754 Review.
A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass.
Hernández-Montoliu L, Rodríguez-Peña MM, Puig R, Astiarraga B, Guerrero-Pérez F, Virgili N, López-Urdiales R, Osorio J, Monseny R, Lazzara C, Sobrino L, Pérez-Maraver M, Pérez-Prieto M, Pellitero S, Fernández-Veledo S, Vendrell J, Vilarrasa N. Hernández-Montoliu L, et al. Among authors: pellitero s. Front Endocrinol (Lausanne). 2023 Oct 17;14:1181744. doi: 10.3389/fendo.2023.1181744. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37916149 Free PMC article. Clinical Trial.
Where are obese people happier?
Caixàs A, Lecube A; Obesity Working Group of the Spanish Society of Endocrinology and Nutrition (GOSEEN). Caixàs A, et al. Endocrinol Nutr. 2014 Jan;61(1):1-2. doi: 10.1016/j.endonu.2013.10.003. Epub 2013 Dec 14. Endocrinol Nutr. 2014. PMID: 24333042 English, Spanish. No abstract available.
Recommendations for the diagnosis and treatment of hypoglycaemia after bariatric surgery.
Vilarrasa N, Bretón I, Ballesteros-Pomar M, Lecube A, Goday A, Pellitero S, Sánchez R, Zugasti A, Ciudin A, de Hollanda A, Rubio MA; GOSEEN (Grupo de Obesidad de la Sociedad Española de Endocrinología y Nutrición). Vilarrasa N, et al. Among authors: pellitero s. Endocrinol Diabetes Nutr (Engl Ed). 2022 Nov;69(9):723-731. doi: 10.1016/j.endien.2021.09.005. Epub 2022 Nov 21. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 36424342 Review.
Lipidome Profiling in Childhood Obesity Compared to Adults: A Pilot Study.
Soria-Gondek A, Fernández-García P, González L, Reyes-Farias M, Murillo M, Valls A, Real N, Pellitero S, Tarascó J, Jenkins B, Galán M, Villarroya F, Koulman A, Corrales P, Vidal-Puig A, Cereijo R, Sánchez-Infantes D. Soria-Gondek A, et al. Among authors: pellitero s. Nutrients. 2023 Jul 27;15(15):3341. doi: 10.3390/nu15153341. Nutrients. 2023. PMID: 37571279 Free PMC article.
[New therapies for type 2 diabetes mellitus].
Puig-Domingo M, Pellitero S. Puig-Domingo M, et al. Among authors: pellitero s. Med Clin (Barc). 2015 Jun 22;144(12):560-5. doi: 10.1016/j.medcli.2014.03.018. Epub 2014 Sep 4. Med Clin (Barc). 2015. PMID: 25194974 Review. Spanish.
Outcomes of Bariatric Surgery in Patients with Cirrhosis.
Miñambres I, Rubio MA, de Hollanda A, Breton I, Vilarrasa N, Pellitero S, Bueno M, Lecube A, Marcuello C, Goday A, Ballesteros MD, Soriano G, Caixàs A. Miñambres I, et al. Among authors: pellitero s. Obes Surg. 2019 Feb;29(2):585-592. doi: 10.1007/s11695-018-3562-8. Obes Surg. 2019. PMID: 30397876
55 results